To address whether NF-κB signaling specifically downstream of the TCR was required for tumor rejection, tumor growth was analyzed in CARMA1-KO mice that lack the key adaptor connecting the TCR to the NF-κB activating machinery. Here, NFKB1 is linked to neoplasm.